In vivo glycan engineering at the cell-matrix interface to control stem cell fate

细胞-基质界面的体内聚糖工程控制干细胞命运

基本信息

  • 批准号:
    8955575
  • 负责人:
  • 金额:
    $ 232.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-30 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Stem cells have the remarkable ability to develop into a range of functional cell types of the adult body that can be used to repair damaged or diseased tissues. Despite advances in achieving selective differentiation in the laboratory, controlling the fate of stem cells post-transplantation still remains an unsolved challenge and a significant obstacle to the use of stem cells as therapeutics. Stem cell specification during development is orchestrated by the concerted action of morphogens, such as growth factors, which initiate intracellular signaling cascades activating gene transcription. Glycans populating surfaces of stem cells play a key role in regulating the interactions of growth factors with their cognate receptors; however, their regulatory functions have been largely unexplored in the context of achieving selectivity in differentiation. The objective of the proposed projects is to create new techniques for manipulating glycan structures at the surface of stem cells to tune the association of endogenous growth factors at the cell-matrix interface in vivo. Two distinct approaches are proposed to achieve this goal. The first approach describes priming of the stem cell surface prior to transplantation with nanoscale glycomimetic materials with affinity for a growth factor of interest. Once the remodeled cells are delivered to a tissue, these materials will promote the association of the endogenous growth factor and activate signaling and differentiation. The second approach outlines the targeted delivery of these materials to the surface of stem cells in vivo concomitant with the inhibition of glycan production in these cells. This in situ remodeling will allow us to temporarily override native glycan signals at a critical junction to achieve selective activation of growth factor signaling and a desired differentiation outcome. This work will provide a novel solution to a key problem in the field of regenerative medicine and will open new opportunities for exploration of the rich biology of glycans for applications in stem cell technologies, tissue engineering and biomedicine.
 描述(由申请人提供):干细胞具有发育成可用于修复受损或患病组织的一系列成人身体功能细胞类型的显著能力。尽管在实验室中实现选择性分化方面取得了进展,但控制移植后干细胞的命运仍然是一个未解决的挑战,也是使用干细胞作为治疗剂的重大障碍。发育过程中的干细胞特化是由形态发生素(如生长因子)的协同作用协调的,这些形态发生素启动细胞内信号级联激活基因转录。干细胞表面的聚糖在调节生长因子与其同源受体的相互作用中起着关键作用;然而,在实现分化选择性的背景下,它们的调节功能在很大程度上尚未被探索。拟议项目的目的是创造新的技术,用于操纵干细胞表面的聚糖结构,以调节体内细胞-基质界面处内源性生长因子的缔合。提出了两种不同的方法来实现这一目标。第一种方法描述了在移植之前用对感兴趣的生长因子具有亲和力的纳米级糖模拟物材料引发干细胞表面。一旦重塑的细胞被递送到组织中,这些材料将 促进内源性生长因子的结合并激活信号传导和分化。第二种方法概述了这些材料的靶向递送到体内干细胞的表面,伴随着这些细胞中聚糖产生的抑制。这种原位重塑将使我们能够暂时覆盖关键连接处的天然聚糖信号,以实现生长因子信号传导的选择性激活和期望的分化结果。这项工作将为再生医学领域的一个关键问题提供一种新的解决方案,并将为探索用于干细胞技术、组织工程和生物医学的聚糖的丰富生物学提供新的机会。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glycocalyx Remodeling with Glycopolymer-Based Proteoglycan Mimetics.
使用基于糖聚合物的蛋白聚糖模拟物进行糖萼重塑。
Biologically Derived Neoproteoglycans for Profiling Protein–Glycosaminoglycan Interactions
用于分析蛋白质与糖胺聚糖相互作用的生物衍生新蛋白聚糖
  • DOI:
    10.1021/acschembio.2c00205
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Porell, Ryan N.;Follmar, Julianna L.;Purcell, Sean C.;Timm, Bryce;Laubach, Logan K.;Kozirovskiy, David;Thacker, Bryan E.;Glass, Charles A.;Gordts, Philip L.;Godula, Kamil
  • 通讯作者:
    Godula, Kamil
Glycocalyx Scaffolding to Control Cell Surface Glycan Displays.
Following sugar patterns in search of galectin function.
遵循糖模式寻找半乳糖凝集素功能。
Stem Cell Microarrays for Assessing Growth Factor Signaling in Engineered Glycan Microenvironments.
  • DOI:
    10.1002/adhm.202101232
  • 发表时间:
    2022-03
  • 期刊:
  • 影响因子:
    10
  • 作者:
    Michalak AL;Trieger GW;Trieger KA;Godula K
  • 通讯作者:
    Godula K
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kamil Godula其他文献

Kamil Godula的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kamil Godula', 18)}}的其他基金

Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
  • 批准号:
    10588085
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
Glycan engineering via exoplasmic Golgi shuttle of glycosylation building blocks and modulators
通过糖基化构件和调节剂的外质高尔基体穿梭进行聚糖工程
  • 批准号:
    9809104
  • 财政年份:
    2019
  • 资助金额:
    $ 232.5万
  • 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
  • 批准号:
    8719535
  • 财政年份:
    2013
  • 资助金额:
    $ 232.5万
  • 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
  • 批准号:
    8728007
  • 财政年份:
    2013
  • 资助金额:
    $ 232.5万
  • 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
  • 批准号:
    8916112
  • 财政年份:
    2013
  • 资助金额:
    $ 232.5万
  • 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
  • 批准号:
    8091489
  • 财政年份:
    2011
  • 资助金额:
    $ 232.5万
  • 项目类别:
NeoProteoglycans as synthetic materials for regenerative medicine and bioimaging
新蛋白聚糖作为再生医学和生物成像的合成材料
  • 批准号:
    8286932
  • 财政年份:
    2011
  • 资助金额:
    $ 232.5万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 232.5万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了